Publicacións en colaboración con investigadores/as de University of Tampere (7)

2024

  1. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

    The Journal of infectious diseases, Vol. 229, Núm. 1, pp. 95-107

2021

  1. Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Versus a Licensed Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine in Meningococcal Vaccine-Naïve and Meningococcal C Conjugate Vaccine-Primed Toddlers: A Phase III Randomized Study

    Epidemiology and Infection

  2. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial

    Vaccine, Vol. 39, Núm. 11, pp. 1598-1608

2020

  1. Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial

    Vaccine, Vol. 38, Núm. 8, pp. 2095-2104

  2. Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial

    Vaccine, Vol. 38, Núm. 8, pp. 2105-2114

2019

  1. TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines

    Human Vaccines and Immunotherapeutics, Vol. 15, Núm. 10, pp. 2405-2415

2018

  1. Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial

    Vaccine, Vol. 36, Núm. 38, pp. 5781-5788